Biotricity, Inc.
BTCY
$0.50
-$0.02-3.85%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 56.23% | 57.68% | -8.25% | 10.48% | 37.83% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -31.13% | -43.01% | 105.44% | 0.86% | 727.20% |
| Total Other Non-Cash Items | -72.24% | -60.97% | 371.59% | -37.46% | 33.69% |
| Change in Net Operating Assets | 51.38% | 84.33% | -81.61% | 28.53% | -45.22% |
| Cash from Operations | 93.25% | 83.38% | 18.44% | 37.93% | 58.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 255.53% | -75.66% | -79.03% | -55.54% | -89.38% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -77.89% | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 1.67% | -1.69% | -100.00% | 100.00% | 97.29% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 118.51% | -86.26% | -34.68% | -10.46% | -82.48% |
| Foreign Exchange rate Adjustments | 84.38% | -101.38% | -268.32% | 39,250.00% | -113.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 130.17% | -93.69% | -32.04% | 489.08% | 45.53% |
